Phase 2 clinical trial of oral lenalidomide, cyclophosphamide, and prednisone (RCP) for newly diagnosed multiple myeloma patients

Category Primary study
JournalBlood
Year 2010
This article has no abstract
Epistemonikos ID: 8bd305e16ab8fa4bce2f397d8038e0f7d05e0664
First added on: Feb 05, 2025